United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
314.12
-8.82 (-2.73%)
Mar 18, 2025, 4:00 PM EST - Market closed
United Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 1,697 | 1,208 | 961.2 | 894.8 | 738.7 | Upgrade
|
| Short-Term Investments | 1,570 | 1,786 | 1,878 | 1,036 | 1,096 | Upgrade
|
| Cash & Short-Term Investments | 3,267 | 2,994 | 2,839 | 1,931 | 1,835 | Upgrade
|
| Cash Growth | 9.11% | 5.47% | 47.03% | 5.22% | 23.49% | Upgrade
|
| Accounts Receivable | 279.3 | 278.9 | 220.4 | 198.7 | 157.4 | Upgrade
|
| Other Receivables | - | 21 | 70 | - | - | Upgrade
|
| Receivables | 279.3 | 299.9 | 290.4 | 198.7 | 157.4 | Upgrade
|
| Inventory | 157.9 | 111.8 | 102 | 93.8 | 86.5 | Upgrade
|
| Other Current Assets | 169.7 | 145.2 | 149.2 | 100.4 | 88.3 | Upgrade
|
| Total Current Assets | 3,874 | 3,551 | 3,380 | 2,324 | 2,167 | Upgrade
|
| Property, Plant & Equipment | 1,222 | 1,045 | 861.5 | 780.9 | 731.6 | Upgrade
|
| Long-Term Investments | 1,534 | 1,938 | 1,345 | 1,681 | 1,234 | Upgrade
|
| Goodwill | 32.3 | 33.7 | 28 | 28 | 28 | Upgrade
|
| Other Intangible Assets | 79.6 | 80.5 | 16.5 | 16.6 | 130.1 | Upgrade
|
| Long-Term Deferred Tax Assets | 458.4 | 394.8 | 327.7 | 261.9 | 238.6 | Upgrade
|
| Other Long-Term Assets | 163.1 | 123.3 | 85.8 | 77.1 | 85.1 | Upgrade
|
| Total Assets | 7,364 | 7,167 | 6,045 | 5,169 | 4,615 | Upgrade
|
| Accounts Payable | 6 | 5.6 | 4.1 | 3.8 | 4.1 | Upgrade
|
| Accrued Expenses | 380.3 | 358.3 | 326.1 | 291.4 | 298.8 | Upgrade
|
| Current Portion of Long-Term Debt | 300 | 400 | - | - | - | Upgrade
|
| Current Portion of Leases | 6.1 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 45.7 | 40.5 | 13 | 10.2 | 20.4 | Upgrade
|
| Total Current Liabilities | 738.1 | 804.4 | 343.2 | 305.4 | 323.3 | Upgrade
|
| Long-Term Debt | - | 300 | 800 | 800 | 800 | Upgrade
|
| Long-Term Leases | 32.5 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 128.1 | 59.5 | 72.6 | 55.9 | 47 | Upgrade
|
| Total Liabilities | 920 | 1,182 | 1,248 | 1,210 | 1,220 | Upgrade
|
| Common Stock | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | Upgrade
|
| Additional Paid-In Capital | 2,699 | 2,549 | 2,388 | 2,245 | 2,149 | Upgrade
|
| Retained Earnings | 7,222 | 6,027 | 5,042 | 4,315 | 3,839 | Upgrade
|
| Treasury Stock | -3,475 | -2,579 | -2,579 | -2,579 | -2,579 | Upgrade
|
| Comprehensive Income & Other | -3.4 | -12.8 | -55.5 | -23 | -14.2 | Upgrade
|
| Shareholders' Equity | 6,444 | 5,985 | 4,797 | 3,959 | 3,395 | Upgrade
|
| Total Liabilities & Equity | 7,364 | 7,167 | 6,045 | 5,169 | 4,615 | Upgrade
|
| Total Debt | 338.6 | 700 | 800 | 800 | 800 | Upgrade
|
| Net Cash (Debt) | 4,404 | 4,204 | 3,355 | 2,781 | 2,185 | Upgrade
|
| Net Cash Growth | 4.75% | 25.31% | 20.65% | 27.28% | 55.66% | Upgrade
|
| Net Cash Per Share | 90.80 | 84.59 | 69.17 | 58.79 | 48.98 | Upgrade
|
| Filing Date Shares Outstanding | 44.91 | 47.06 | 46.3 | 45.13 | 44.54 | Upgrade
|
| Total Common Shares Outstanding | 44.83 | 47.04 | 46.03 | 45.11 | 44.51 | Upgrade
|
| Working Capital | 3,136 | 2,747 | 3,037 | 2,018 | 1,844 | Upgrade
|
| Book Value Per Share | 143.74 | 127.23 | 104.20 | 87.77 | 76.28 | Upgrade
|
| Tangible Book Value | 6,332 | 5,871 | 4,752 | 3,914 | 3,237 | Upgrade
|
| Tangible Book Value Per Share | 141.24 | 124.80 | 103.24 | 86.78 | 72.73 | Upgrade
|
| Land | 181.9 | 148 | 142.7 | 132.6 | 74.9 | Upgrade
|
| Buildings | 863.8 | 685.3 | 636.7 | 612.7 | 593.6 | Upgrade
|
| Machinery | 449.7 | 381.2 | 353.9 | 322.9 | 325 | Upgrade
|
| Construction In Progress | 218.2 | 259.1 | 110.9 | 55.1 | 47.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.